Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $63.7M | $92.4M | $38.5M | $68.9M | $53.4M | $115.9M | $139.5M | $120.5M | $161.2M | $167.4M | $175.1M | $133.4M | $269.8M | $296.6M | $277.1M | $303.9M | $540.4M | $636.0M | $394.1M | $772.9M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, IDEXX Laboratories, Inc.'s last 12-month Free Cash Flow is $575.3M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, IDEXX Laboratories, Inc.'s Free Cash Flow growth was (25.6%). The average annual Free Cash Flow growth rates for IDEXX Laboratories, Inc. have been (6.1%) over the past three years, 13.6% over the past five years.
Over the last year, IDEXX Laboratories, Inc.'s Free Cash Flow growth was (25.6%), which is lower than industry growth of (0.4%). It indicates that IDEXX Laboratories, Inc.'s Free Cash Flow growth is Bad.